hsandm, Author at HSandM Magazine

Menu

Menu

Latest stories

Andrew Hirsch Named Chief Executive Officer of C4 Therapeutics

Hologic Announces Pricing of Offering of $950 Million of 3.250% Senior Notes Due 2029

Paul Gonsalves Joins Orthofix as President of Global Extremities Business

More stories

in Headlines

Andrew Hirsch Named Chief Executive Officer of C4 Therapeutics

September 18, 2020, 10:35 am
in Headlines

Hologic Announces Pricing of Offering of $950 Million of 3.250% Senior Notes Due 2029

September 18, 2020, 10:34 am
in Headlines

Paul Gonsalves Joins Orthofix as President of Global Extremities Business
in Headlines

Outset Medical Stock More than Doubles after IPO Scores a Target-Topping $242M

September 18, 2020, 10:31 am
in Headlines

Gilead to Acquire Immunomedics for $21 Billion

September 18, 2020, 10:29 am
in Headlines

Former SVP and President for Walmart Health Pivots to Modernize the Testing Industry

September 4, 2020, 12:38 pm
in Headlines

Gilead commits $120M with $685M in future potential to Jounce

September 4, 2020, 12:36 pm
in Headlines

CM Life Sciences, Inc., Sponsored by Affiliates of Casdin Capital and Corvex Management, Announces Pricing of Upsized $385 Million Initial Public Offering

September 4, 2020, 10:39 am
in Headlines

Galectin Therapeutics Appoints Joel Lewis as Chief Executive Officer
in Headlines

Danaher Appoints Rainer M. Blair as President and CEO

September 4, 2020, 10:36 am
in Headlines

Nestle Pays $2 Billion to Secure Aimmune’s Allergy Treatment

September 4, 2020, 10:35 am
in Headlines

Former SVP and President for Walmart Health Pivots to Modernize the Testing Industry

September 4, 2020, 10:35 am

Congratulations. You've reached the end of the internet.

Back to Top

Close